¼º±âÈÆ ¸íÀÇ

¼º±âÈÆ ¸íÀÇ

  • ¼Ò ¼Ó
    °¡Ãµ´ë ±æº´¿ø
  • Áø·á°ú
    ¹æ»ç¼±Á¾¾çÇаú
  • Àü¹®ºÐ¾ß
    À¯¹æ¾Ï, ½Äµµ¾Ï, À§¾Ï

¸íÀÇÇÁ·ÎÇÊ ¸íÀÇ ÇÁ·ÎÇÊ

ÇзÂ

Educational Background
  • °¡Ãµ´ë ÀÇ´ë ¹Ú»ç

ÁÖ¿ä°æ·Â

Work Experience
  • úÞ) °¡Ãµ´ë ±æº´¿ø Áø·áÁö¿øºÎÀå
  • úÞ) °¡Ãµ´ë ±æº´¿ø ¹æ»ç¼±Á¾¾çÇаú Á¶±³¼ö

ÇÐȸȰµ¿

Academic activities
  • 2015 ~ ÇöÀç´ëÇѹæ»ç¼±Á¾¾çÇÐȸ Á¤È¸¿ø
  • 2015 ~ ÇöÀçÀ¯·´¹æ»ç¼±Á¾¾çÇÐȸ Á¤È¸¿ø
  • 2017 ~ 2019[¿¬±¸Ã¥ÀÓÀÚ] À¯¹æ¾Ï ¼¼±âÁ¶Àý¹æ»ç¼±Ä¡·á¸¦ À§ÇÑ 4Â÷¿ø È£Èí¿¬µ¿ ¸ð¼ÇÆÒÅÒ °³¹ß
  • 2017 ~ 2019[¿¬±¸Ã¥ÀÓÀÚ] À¯¹æ¾ÏÀÇ ¹æ»ç¼±Ä¡·á ½Ã ÇǺεµÆ÷Á¦Á¦¸¦ ÀÌ¿ëÇÑ ¹æ»ç¼±ÇǺο°ÀÇ ¿¹¹æ ¹× Ä¡·áÈ¿°ú ¿¬±¸
Àú¼­ ¾ÆÀÌÄÜ

ÁýÇÊÀú¼­

ÃÑ 0°Ç
¿¬±¸ ¾ÆÀÌÄÜ

ÁÖ¿ä³í¹®

ÃÑ 7°Ç
Á¦ ¸ñ Reducing radiation dermatitis using a film-forming silicone gel during breast radiotherapy: A pilot randomized-controlled trial. In Vivo, 2020. 34(1).
¹ßÇ¥³âµµ 2020 ¹ßÇ¥Áö
Á¦ ¸ñ Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea. Can J Gastroenterol Hepatol, 2019: p. 8072928.
¹ßÇ¥³âµµ 2019 ¹ßÇ¥Áö
Á¦ ¸ñ Dose gradient curve: A new tool for evaluating dose gradient. PLoS One, 2018. 13(4): p. e0196664.
¹ßÇ¥³âµµ 2018 ¹ßÇ¥Áö
Á¦ ¸ñ Orbital volume restoration rate after orbital fracture; a CT-based orbital volume measurement for evaluation of orbital wall reconstructive effect. Eye (Lond), 2017. 31(5): p. 713-719.
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö
Á¦ ¸ñ Cardiac risk index as a simple geometric indicator to select patients for the heart-sparing radiotherapy of left-sided breast cancer. J Med Imaging Radiat Oncol, 2017. 61(3): p. 410-417.
¹ßÇ¥³âµµ 2017 ¹ßÇ¥Áö
Á¦ ¸ñ Clinical applicability of biologically effective dose calculation for spinal cord in fractionated spine stereotactic body radiation therapy. Radiol Oncol, 2015. 49(2): p. 185-91.
¹ßÇ¥³âµµ 2015 ¹ßÇ¥Áö
Á¦ ¸ñ Cardiac dose reduction with breathing adapted radiotherapy using self respiration monitoring system for left-sided breast cancer. Radiat Oncol J, 2014. 32(2): p. 84-94.
¹ßÇ¥³âµµ 2014 ¹ßÇ¥Áö

¸íÀÇqna ¸íÀÇ ¼Ò¼Óº´¿ø

°¡Ãµ´ë ±æº´¿ø

»ó±ÞÁ¾ÇÕº´¿ø
ÀüÈ­ ¾ÆÀÌÄÜ ´ëÇ¥¹øÈ£
1577-2299
À¥»çÀÌÆ® ¾ÆÀÌÄÜȨÆäÀÌÁö

ÁÖ¿ä½Ã¼³

ÀÀ±Þ½Ç ÀÀ±Þ½Ç
Ŭ¸®´Ð Ŭ¸®´Ð
Á¾ÇÕ°ËÁø¼¾ÅÍ Á¾ÇÕ°ËÁø¼¾ÅÍ
¾Ï¼¾ÅÍ ¾Ï¼¾ÅÍ
ÁÖÂ÷½Ã¼³ ÁÖÂ÷½Ã¼³

°¡Ãµ´ë±æº´¿øÀº º´»ó¼ö¸¦ ±âÁØÀ¸·Î ÇØ¼­ ±¹³» 5¹øÂ° Á¾ÇÕ ÀÇ·á±â°üÀ¸·Î Æø³ÐÀº ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Ù. ½ÉÀå¼¾ÅÍ¿Í ³ú½Å°æ¼¾ÅÍ, ¾È¤ýÀ̺ñÀÎÈļ¾ÅÍ, Ä¡°ú¼¾ÅÍ, ¿©¼ºÀü¹®¼¾ÅÍ, ÀÎõ ¼­ÇØ ±Ç¿ª ÀÀ±ÞÀÇ·á¼¾ÅÍ, ¾Ï¼¾ÅÍ µî Àü¹® ÀÇ·á¼¾Å͸¦ °®Ãß°í ÀÖÀ¸¸ç, À̸¦ ¹ÙÅÁÀ¸·Î ½ÉÇ÷°ü½ÉÆ÷Áö¾ö, ³úôÃ߽Ű泻½Ã°æ¿öÅ©¼ó, ´ëü¤ýº¸¿ÏÀÇÇм¼¹Ì³ª µî ±¹Á¦ ±Ô¸ðÀÇ Çмú´ëȸ¸¦ ¸Å³â °³ÃÖÇϰí ÀÖ´Ù.

°¡Ãµ´ë ±æº´¿ø À̹ÌÁö

ÀÎõ±¤¿ª½Ã ³²µ¿±¸ ³²µ¿´ë·Î 774¹ø±æ 21

Ȩ
³»°¡ ¾Ë°íÀÖ´Â ¸íÀǸ¦ ÃßÃµÇØÁÖ¼¼¿ä